Caricamento...
Btk inhibitors in atherosclerosis
In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.(1)
Salvato in:
| Pubblicato in: | Blood |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032894/ https://ncbi.nlm.nih.gov/pubmed/29903867 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-04-841916 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|